Author

Inga Galuba

Novartis (Switzerland)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adrienn Volak· 1 shared Álvaro Herrero-NavarroiD· 1 shared Botond RoskaiD· 1 shared Cameron S. CowaniD· 1 shared Daniel K. BaeschliniD· 1 shared Isabelle Claerr· 1 shared Jannick Imbach· 1 shared Josephine JüttneriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Adrienn Volak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell type-focused compound screen in human organoids reveals CK1 and MAPK11 inhibition protects cone photoreceptors from death

Stefan Erich Spirig, Álvaro Herrero-Navarro, Larissa Utz, Valeria J. Arteaga-Moreta, Zoltán Raics, Susana Posada-Céspedes, Stéphanie Chreng, Olaf Galuba, Inga Galuba, Isabelle Claerr, Steffen Renner, Miklos Boldogkoi, Verónica Moreno‐Juan, P. Timo Kleindienst, Adrienn Volak, , Botond Roska

The paper screens 2,707 compounds in human retinal organoids to identify those that protect or damage cone photoreceptors, finding CK1 and MAPK11 inhibitors as protective.

Neuron · Mar 30, 2026Peer-reviewedNeuroscience